ACR, SBI to petition FDA on mammography regulations

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

David Dershaw, MD, of the ACR Breast Imaging Government Relations Committee and Carol Lee, MD, president of the Society of Breast Imaging (SBI), will petition the FDA’s national Mammography Quality Assurance Advisory (MQSA) committee to lift the exemption of stereotactic breast biopsy from its regulations at a Nov. 5 hearing in Rockville, Md.

The committee will discuss issues related to possible regulation of interventional mammography procedures, such as stereotactic breast biopsy; receive input from consumer advocates and several professional organizations; and receive updates on recently approved alternative standards.